Ads
related to: herceptin- ENHERTU Dosing
Find ENHERTU Dosing & Admin
Resources For Your Practice.
- Downloadable Resources
Access ENHERTU Downloadable
Resources For Your Patients.
- Efficacy & Safety Data
Learn More About The
Efficacy & Safety Data For ENHERTU.
- Register For Updates
Register Today To Receive
Updates on ENHERTU. HCP Site.
- ENHERTU Information
Visit To Learn More About
ENHERTU For Your Practice.
- Access & Support
View Helpful Patient Support Info
On The Official HCP Website.
- ENHERTU Dosing
Search results
ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer
Pharmaceutical Technology via Yahoo Finance· 5 days agoThe current standard of care in the first line is a combination of Genentech’s Herceptin...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 8 hours agoThe technology is behind some of the biggest medicines on the market, including Johnson & Johnson's...
UCLA oncologist Dr. Dennis Slamon awarded Szent-Gy | Newswise
Newswise· 3 days agoDr. Dennis Slamon, a world-renowned oncologist and scientist whose groundbreaking research has...
ASCO24: Can Ambrx’s novel ADC break into the metastatic breast cancer market?
Pharmaceutical Technology via Yahoo Finance· 4 days agoARX788 (anvatabart opadotin), a HER2-targeting antibody conjugated to Amberstatin 269 with a...
Top Analyst Reports for Roche, Wells Fargo & GE Aerospace
Zacks via Yahoo Finance· 3 days agoToday's Research Daily features new research reports on 16 major stocks, including Roche Holding AG...
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks via Yahoo Finance· 3 days agoIn 2024, Teva expects Uzedy sales of approximately $80 million. Teva markets biosimilar versions of...
Astra's Enhertu breast cancer trial shows 'unprecedented' results
Reuters via Yahoo News· 5 days ago(Reuters) -AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about...
ASCO: Jazz shares 'unprecedented' HER2 biliary tract cancer data ahead of FDA decision
FierceBiotech· 6 days agoAs zanidatamab awaits an FDA approval decision, Jazz Pharmaceuticals is sharing
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1...
Benzinga· 6 days agoEvorpacept in combination with PADCEV®, an approved antibody-drug conjugate ("ADC"), demonstrated promising activity and was generally well toleratedCompany to host conference call and webcast with Samuel A. Funt,
Ads
related to: herceptin